Skip to main content
Log in

Impact of Presarcopenic Dysphagia on 1-Year Mortality After Videofluoroscopic Swallowing Study in Patients with Cancer

  • Original Article
  • Published:
Dysphagia Aims and scope Submit manuscript

Abstract

Sarcopenic dysphagia is the term for swallowing difficulty associated with loss of mass, strength, and physical performance, which leads to increased pharyngeal residues. Unlike sarcopenia, presarcopenia is characterized by low muscle mass without decreased muscle strength or physical performance and can develop into dysphagia due to low skeletal muscle mass. This retrospective study investigated the impact of presarcopenic dysphagia (PSD) on 1-year mortality in patients with cancer and dysphagia who underwent a videofluoroscopic swallowing study (VFSS). An operational definition of PSD based on presarcopenia and pharyngeal residues was adopted. The psoas muscle mass index (cm2/height [m2]), calculated by the psoas muscle area at the third lumber vertebra via abdominal computed tomography (CT) and related to height, was used to assess presarcopenia with cutoff values of 4.62 for men and 2.66 for women. Pharyngeal residues were assessed using a VFSS to evaluate dysphagia. Patients’ medical charts were analyzed to investigate 1-year mortality after a VFSS. Out of 111 consecutive patients with cancer, 53 (47.7%) were defined as having PSD. In a forward-stepwise Cox proportional regression analysis, PSD (HR 2.599; 95% CI 1.158–5.834; p = 0.021) was significantly associated with 1-year mortality after a VFSS, even after adjusting for the factors of operation, Functional Oral Intake Scale (FOIS) scores at discharge, and modified Barthel Index (BI) scores at discharge. PSD, defined as CT-based presarcopenia and pharyngeal residues observed during a VFSS, is associated with increased 1-year mortality in patients with cancer and dysphagia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

All data are not publically available owing to opt-out restrictions. Data sharing is not applicable.

References

  1. Fujisihima I, Fujiu-Kurachi M, Arai H, et al. Sarcopenia and dysphagia: position paper by four professional organizations. Geriatr Gerontol Int. 2019;19:91–7. https://doi.org/10.1111/ggi.13591.

    Article  Google Scholar 

  2. Pamoukdjian F, Bouillet T, Lévy V, et al. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review. Clin Nutr. 2018;37:1101–13. https://doi.org/10.1016/j.clnu.2017.07.010.

    Article  PubMed  Google Scholar 

  3. Otten L, Stobäus N, Franz K, et al. Impact of sarcopenia on 1-year mortality in older patients with cancer. Age Ageing. 2019;48:413–8. https://doi.org/10.1093/ageing/afy212.

    Article  PubMed  Google Scholar 

  4. Frowen J, Hughes R, Skeat J. The prevalence of patient-reported dysphagia and oral complications in cancer patients. Support Care Cancer. 2020;28:1141–50. https://doi.org/10.1007/s00520-019-04921-y.

    Article  PubMed  Google Scholar 

  5. Molfenter SM, Amin MR, Branski RC, et al. Age-related changes in pharyngeal lumen size: a retrospective MRI analysis. Dysphagia. 2015;30:321–7. https://doi.org/10.1007/s00455-015-9602-9.

    Article  PubMed  Google Scholar 

  6. Miyashita T, Kikutani T, Nagashima K, et al. The effects of sarcopenic dysphagia on the dynamics of swallowing organs observed on videofluoroscopic swallowing studies. J Oral Rehabil. 2020;47:584–90. https://doi.org/10.1111/joor.12936.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23. https://doi.org/10.1093/ageing/afq034.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Hanna L, Nguo K, Furness K, et al. Association between skeletal muscle mass and quality of life in adults with cancer: a systematic review and meta-analysis. J Cahexia Sarcopenia Muscle. 2022;13:839–57. https://doi.org/10.1002/jcsm.12928.

    Article  Google Scholar 

  9. Sakai M, Sohda M, Saito H, et al. Impact of combined assessment of systemic inflammation and presarcopenia on survival for surgically resected esophageal cancer. Am J Surg. 2021;221:149–54. https://doi.org/10.1016/j.amjsurg.2020.05.029.

    Article  PubMed  Google Scholar 

  10. Takada H, Kurosaki M, Nakanishi H, et al. Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma. PLoS ONE. 2018;13:e0198812. https://doi.org/10.1371/journal.pone.0198812.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Takada H, Amemiya F, Yasumura T, et al. Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma. Sci Rep. 2020;10:10186. https://doi.org/10.1038/s41598-020-67147-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bahat G, Turkmen BO, Aliyev S, et al. Cut-off values of skeletal muscle index and psoas muscle index at L3 vertebra level by computerized tomography to assess low muscle mass. Clin Nutr. 2021;40:4360–5. https://doi.org/10.1016/j.clnu.2021.01.010.

    Article  PubMed  Google Scholar 

  13. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. A simple index of independence useful in scoring improvement in the rehabilitation of the chronically ill. Md State Med J. 1965;14:61–5.

    CAS  PubMed  Google Scholar 

  14. Crary MA, Mann GDC, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil. 2005;86:1516–20. https://doi.org/10.1016/j.apmr.2004.11.049.

    Article  PubMed  Google Scholar 

  15. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83. https://doi.org/10.1016/0021-9681(87)90171-8.

    Article  CAS  PubMed  Google Scholar 

  16. Campo-Rivera N, Ocampo-Chaparro JM, Carvajal-Ortiz R, et al. Sarcopenic dysphagia is associated with mortality in institutionalized older adults. J Am Med Dir Assoc. 2022;23:1720.e11-1720.e17. https://doi.org/10.1016/j.jamda.2022.06.016.

    Article  PubMed  Google Scholar 

  17. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8. https://doi.org/10.1038/bmt.2012.244.

    Article  CAS  PubMed  Google Scholar 

  18. Wakabayashi H. Presbyphagia and sarcopenic dysphagia: association between aging, sarcopenia, and deglutition disorders. J Frailty Aging. 2014;3:97–103. https://doi.org/10.14283/jfa.2014.8.

    Article  CAS  PubMed  Google Scholar 

  19. Hamaguchi Y, Kaido T, Okumura S, et al. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition. 2016;32:1200–5. https://doi.org/10.1016/j.nut.2016.04.003.

    Article  PubMed  Google Scholar 

  20. Wakabayashi H, Takahashi R, Watanabe N, et al. Prevalence of sarcopenia and its association with dysphagia in cancer patients who require rehabilitation. J Rehabil Med. 2017;49:682–5. https://doi.org/10.2340/16501977-2253.

    Article  PubMed  Google Scholar 

  21. Mayanagi S, Ishikawa A, Matsui K, et al. Association of preoperative sarcopenia with postoperative dysphagia in patients with thoracic esophageal cancer. Dis Esophagus. 2021;34:doaa121. https://doi.org/10.1093/dote/doaa121.

    Article  PubMed  Google Scholar 

  22. Clavé P, Arreola V, Romea M, et al. Accuracy of the volume-viscosity swallow test for clinical screening of oropharyngeal dysphagia and aspiration. Clin Nutr. 2008;27:806–15. https://doi.org/10.1016/j.clnu.2008.06.011.

    Article  PubMed  Google Scholar 

  23. Mizuno S, Wakabayashi H, Fujishima I, et al. Construction and quality evaluation of the Japanese Sarcopenic Dysphagia Database. J Nutr Health Aging. 2021;25(7):926–32. https://doi.org/10.1007/s12603-021-1646-y.

    Article  CAS  PubMed  Google Scholar 

  24. Wu BW, Yin T, Cao WX, et al. Clinical application of subjective global assessment in Chinese patients with gastrointestinal cancer. World J Gasteroenterol. 2009;15:3542–9. https://doi.org/10.3748/wjg.15.3542.

    Article  Google Scholar 

  25. Pressoir M, Desné S, Berchery D, et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer. 2010;102:966–71. https://doi.org/10.1038/sj.bjc.6605578.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Braun DP, Gupta D, Staren ED. Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer. 2011;11:353. https://doi.org/10.1186/1471-2407-11-353.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kenis C, Decoster L, Bastin J, et al. Functional decline in older patients with cancer receiving chemotherapy: a multicenter prospective study. J Geriatr Oncol. 2017;8:196–205. https://doi.org/10.1016/j.jgo.2017.02.010.

    Article  PubMed  Google Scholar 

  28. Morishma T, Sato A, Nakata K, et al. Geriatric assessment domains to predict overall survival in older cancer patients: an analysis of functional status, comorbidities, and nutritional status as prognostic factors. Cancer Med. 2020;16:5839–50. https://doi.org/10.1002/cam4.3205.

    Article  CAS  Google Scholar 

Download references

Funding

This study was not financially supported.

Author information

Authors and Affiliations

Authors

Contributions

TM conceived the idea of the study, developed the statistical analyses, and drafted the original manuscript on intellectual content. AH and YM contributed to interpreting the results and revised the original manuscript. MT, RH, HT, HI, and MO contributed to collecting the data for the study. SS supervised the conduct of the study. All Authors reviewed the manuscript draft and approved publishing the final version.

Corresponding author

Correspondence to Toshiyuki Moriyama.

Ethics declarations

Conflict of Interests

The authors declare no conflict of interest.

Ethical Approval

This study was conducted under the Declaration of Helsinki and with the approval of the Ethics Committee of the University Hospital of Occupational and Environmental Health, Japan [UOEHCRB22-144]. Written informed consent was not obtained because of the retrospective observational nature of the study. Nevertheless, all patients were allowed to provide an opt-out option to withdraw from the study at any time.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moriyama, T., Hachisuka, A., Matsusihima, Y. et al. Impact of Presarcopenic Dysphagia on 1-Year Mortality After Videofluoroscopic Swallowing Study in Patients with Cancer. Dysphagia (2024). https://doi.org/10.1007/s00455-023-10652-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00455-023-10652-4

Keywords

Navigation